Pregnant women, aged 18 or over, receiving antenatal care at King Chulalongkorn Memorial Hospital (KCMH), undergoing routine cervical cancer screening, and agreeing to participate in this study. HPV infection, prevalence, pregnancy, adverse pregnancy outcomes
Conditions
Interventions
Pregnant women with positive HPV DNA from cervical specimen,Pregnant women with negative HPV DNA from cervical specimen
Other,Other
High-risk HPV positive,High-risk HPV negative
Sponsors
Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. All confirmed pregnant women 2. Aged 18 or over 3. Receiving antenatal care at KCMH 4. Willing to receive a routine PAP smear 5. Agree to participate in this research with a given written informed consent.
Exclusion criteria
Exclusion criteria: 1) Pregnant women who are contraindicated for pelvic examination. a. Active vaginal bleeding b. Vasa previa c. Placenta previa d. Preterm premature rupture of membrane 2) In labor or rupture of membrane. 3) Pelvic examination is impossible to perform, such as large vulvar mass. 4) Quit or changed.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of high-risk Human Papillomavirus infection in pregnant women in Thailand. At the time of the specimen collection Prevalence | — |
Secondary
| Measure | Time frame |
|---|---|
| Prevalence of abnormal cytology in pregnant women in Thailand. At the time of specimen collection Prevalence,Relation between HPV infection and rate of adverse pregnancy outcomes After abortion or delivery Rate of abortion, preterm delivery, preterm premature rupture of membrane, hypertensive disorder in pregnancy, fetal growth restriction, low birth weight, intrauterine fetal death | — |
Countries
Thailand
Contacts
Public ContactThanapornphan Pokchainun
Faculty of Medicine, Chulalongkorn University
Outcome results
None listed